SkinMedica Named 2010 Fastest Growing Skin Care Brand for Fifth Consecutive Year

CARLSBAD, Calif., March 28, 2011 /PRNewswire/ -- SkinMedica has been named the 2010 fastest growing skin care brand in the U.S. This marks the fifth consecutive year SkinMedica has earned the title of fastest growing skin care company in the medical channel. The Kline & Company study, featured in the April 2011 issue of WWD Beauty, Inc., also reports that the global professional skin care products market grew in sales as well as the number of visits to professional outlets for skin care treatments in 2010.

(Logo:  http://photos.prnewswire.com/prnh/20100810/NY48207LOGO)

Ted Schwarz, President of SkinMedica, comments, "Our loyal professional partners credit the combination of ground-breaking products with a devoted sales and education team as the difference between SkinMedica and other brands. This allows us the ability to dynamically grow our brand and continue to advance the professional skin care market."    

Highly regarded among medical professionals, SkinMedica is known for its diverse product offering and efficacious formulas, namely the exclusive, highly-coveted growth factor blend TNS.  The company's most recent launch, Redness Relief CalmPlex is the first and only non-prescription product clinically proven to reduce the appearance of visible redness in as little as two weeks.

About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring and commercializing products that treat dermatologic conditions and improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The Company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum™ and hallmark TNS Recovery Complex®. The formulations in the Company's clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.

SkinMedica's prescription products include VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women and EpiQuin® Micro Cream (4% hydroquinone) for hyperpigmentation, or "brown spots" that commonly result from aging, inflammation or sun exposure.

SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.

TNS Recovery Complex®, VANIQA®, EpiQuin® Micro, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.

About Kline

Kline is a worldwide consulting and research firm dedicated to providing the kind of insight and knowledge that helps companies find a clear path to success. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries over 50 years. For more information, visit www.klinegroup.com.

SOURCE SkinMedica, Inc.